Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Enlivex $7.5M Registered Direct Offering, November 2026

Enlivex Ltd. filed a Form 6-K with the U.S. Securities and Exchange Commission on November 16, 2026, disclosing a securities purchase agreement for a registered direct offering of up to $7,500,000 in ordinary shares and accompanying warrants.

Manish Choudhary | 16 November 2026

LanzaTech Reports Q3 2026 with 13,089,197 Shares Outstanding

LanzaTech Global, Inc. filed a quarterly report on Form 10-Q with the SEC covering the period ended September 30, 2026, disclosing consolidated balance sheet data, share counts, and ongoing business developments including activities related to its gas fermentation and carbon capture technology operations.

Shwetambri Chauhan | 16 November 2026

Ticketplus Launches Platform in Bolivia as 13th Active Market

Ticketplus Ltd. filed a Form 6-K with the SEC on November 16, 2026, announcing the official launch of its ticketing platform in Bolivia, which the company described as its 13th active market.

Vinay Lochav | 16 November 2026

Tyson Foods Files Annual Report for Fiscal Year Ended October 3, 2026

Tyson Foods, Inc. filed its Annual Report on Form 10-K with the U.S. Securities and Exchange Commission for the fiscal year ended October 3, 2026, disclosing share counts, segment structure, and business operations across its five reportable segments.

Anjali Anand | 16 November 2026

Vivo Opportunity Fund Discloses 9.99% Stake in Unicycive

Vivo Opportunity Fund Holdings, L.P. and affiliated entities filed Amendment No. 5 to a beneficial ownership statement with the SEC on November 16, 2026, disclosing a 9.99% position in Unicycive Therapeutics, Inc. (NASDAQ:UNCY) as of September 30, 2026.

Aakashdeep | 16 November 2026

Galectin Therapeutics Reports Q3 2026 Net Loss of $3.5M

Galectin Therapeutics Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026, with the SEC on November 16, 2026, disclosing a net loss of $3,531,000 for the third quarter and reporting significant changes to its balance sheet following the conversion of …

Vinay Lochav | 16 November 2026

Lightwave Acquisition Corp. Reports Q3 2026 Results

Lightwave Acquisition Corp. filed a Form 10-Q with the SEC on November 16, 2026, covering the quarter ended September 30, 2026, disclosing financial results and trust account balances for the blank-check company listed on NASDAQ:LWAC.

Nitish Kishor | 16 November 2026

Radcom Director Sami Totah Sells 6,000 Shares at $11

Director Sami Totah filed a Form 4 with the SEC on November 16, 2026, disclosing the sale of 6,000 ordinary shares of RADCOM LTD on November 12, 2026.

Manish Choudhary | 16 November 2026

Forbion Discloses 8.4% Stake in MapLight Therapeutics

Forbion Growth Opportunities Fund III Cooperatief U.A. and Forbion Growth III Management B.V. filed an amended Schedule 13G with the SEC on November 16, 2026, disclosing beneficial ownership of 4,428,328 shares of MapLight Therapeutics, Inc. voting common stock as of September 30, 2026.

Nitish Kishor | 16 November 2026

Radcom CTO Ram Amit Sells 3,000 Shares at $10.99

Ram Amit, Chief Technology Officer of Radcom Ltd., filed a Form 4 on November 16, 2026, disclosing the sale of 3,000 ordinary shares on November 13, 2026.

Aditi Sarkar | 16 November 2026
Support

Hi! How can we help you today?

Loading…